Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06946550 · ClinicalTrials.gov registry record · NA
Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
A NA study of Scarring Alopecia, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06946550 is a NA study of Scarring Alopecia that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06946550, a NA study of Scarring Alopecia, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the effectiveness of a non-ablative 1470 nm laser in treating scarring alopecia in adults. The study will also investigate the biochemical molecular pathways involved in laser therapy by analyzing hair follicle gene expression before and after laser treatment. The main questions it aims to answer are: 1. Does a non-ablative laser work to effectively treat scarring alopecia? 2. What molecular pathways are associated with the laser's effects on hair follicles in scarring alopecia? Participants with scarring alopecia will: * Receive 3 laser treatments, spaced 1 month apart (Month 1, Month 2, Month 3), and attend 5 follow-up visits (Month 4, Month 6, Month 9, Month 12 and Month 15) * Have hair follicle samples collected via hair plucking of 10 hairs prior to the start and 1-month post-completion of laser treatments for gene expression analysis of inflammatory and fibrosis pathways implicated in scarring alopecia. Hair samples will be de-identified and kept anonymous. * Fill out questionnaires at each visit * Keep a diary of any side effects from laser treatments
Conditions Studied
Interventions
- DEVICE 1470nm non-ablative fractional laser
Study Locations (1)
New York
- Montefiore Einstein Advanced Care - Elmsford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-12-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06946550
The ClinicalTrials.gov registry entry for NCT06946550 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Scarring Alopecia appearing as the primary indexed condition, and to 1 intervention - of which 1470nm non-ablative fractional laser is the first listed.
NCT06946550 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06946550 about?
NCT06946550 is a clinical study titled "Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis". The goal of this clinical trial is to evaluate the effectiveness of a non-ablative 1470 nm laser in treating scarring alopecia in adults. The study will also investigate the biochemical molecular pathways involved in laser therapy by analyzing hair follicle gene expression before and after laser tre...
What is the current status of trial NCT06946550?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-12-09. Estimated completion is 2027-12.
What conditions does trial NCT06946550 study?
This clinical trial studies the following conditions: Scarring Alopecia.
What interventions are being tested in trial NCT06946550?
The interventions under investigation include: 1470nm non-ablative fractional laser (DEVICE).
Who is sponsoring clinical trial NCT06946550?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06946550 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scarring Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.